MedPath

Evaluation of the effect of uterine flushing with human chorionic gonadotropin (hCG) on biochemical and clinical pregnancy rate in the IUI cycle of couples with idiopathic infertility

Phase 3
Recruiting
Conditions
Female infertility.
Female infertility, unspecified
N97.9
Registration Number
IRCT20220702055335N1
Lead Sponsor
Vice chancellor for Research,Tabriz
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
80
Inclusion Criteria

Having an informed consent to participate in the study
Unexplained infertility diagnosis
The health of the uterus structure
Normal sperm analysis
Women between 20 and 38 years old
The presence of ovulation

Exclusion Criteria

unsatisfaction for the participation of study
Moderate to severe endometriosis
hyper prolactinemia
Hyperthyroidism
Hypothyroidism
Ovarian Cysts
Kidney and liver failure
Blocked fallopian tubes
Increased FSH

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical pregnancy rate. Timepoint: 28 days after transfer. Method of measurement: vaginal sonography.;Chemical pregnancy rate. Timepoint: 14 days after transfer. Method of measurement: BhCG test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath